Dr. Paraghamian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Boston, MA 02111Phone+1 617-636-6058Fax+1 617-636-3258
Education & Training
- University of North Carolina HospitalsFellowship, Gynecologic Oncology, 2018 - 2021
- University of California (Irvine)Residency, Obstetrics and Gynecology, 2014 - 2018
- University of North Carolina at Chapel Hill School of MedicineClass of 2014
Certifications & Licensure
- MA State Medical License 2021 - 2026
- NH State Medical License 2022 - 2026
- NC State Medical License 2018 - 2021
- CA State Medical License 2016 - 2019
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- 62 citationsMetastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report.Sarah E. Paraghamian, Teresa C. Longoria, Ramez N. Eskander
Gynecologic Oncology Research and Practice. 2017-02-02 - 3 citationsLinoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer.Jianqing Qiu, Ziyi Zhao, Hongyan Suo, Sarah E Paraghamian, Gabrielle M Hawkins
Cancer Biology & Therapy. 2024-12-31 - 14 citationsONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro.Y. Zhang, Yu Huang, Yajie Yin, Yali Fan, Wenchuan Sun
Frontiers in Oncology. 2020-10-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: